Success Stories: Nepalese Teaching Associate and Technical Sales Specialist in Microbiology Earns EB2-NIW Approval
Client’s Testimonial:
“Thank you for your help throughout the process.”
On April 5th, 2025, we received another EB-2 NIW (National Interest Waiver) approval for a Teaching Associate and Technical Sales Specialist in the Field of Microbiology (Approval Notice).
General Field: Microbiology
Position at the Time of Case Filing: Teaching Associate and Technical Sales Specialist
Country of Origin: Nepal
Country of Residence at the Time of Filing: Australia
Approval Notice Date: April 5th, 2025
Processing Time: 1 year and 4 months
Case Summary:
A Teaching Associate and Technical Sales Specialist from Nepal, with a Ph.D. in biochemistry and molecular biology, contacted our law firm for assistance in filing an EB-2 NIW (National Interest Waiver) petition. With a specialized research background in combating antibiotic-resistant bacterial infections, we built a petition strategy that emphasized the national relevance of his proposed endeavor and the strength of his scientific credentials.
His proposed work focuses on developing vaccines through advanced molecular biology and immunological approaches to address bacterial pathogens that have become resistant to standard antibiotic treatments. One of his primary research targets is Neisseria gonorrhoeae, a sexually transmitted bacterium now considered a major antimicrobial resistance threat in the U.S. due to its rapid evolution against multiple lines of treatment.
This work directly aligns with urgent national health priorities. Antimicrobial resistance is responsible for millions of infections and tens of thousands of deaths each year in the United States. By contributing novel strategies for vaccine design, the client’s work offers significant potential to reduce the disease burden, improve treatment outcomes, and lower long-term healthcare costs.
To demonstrate his qualifications to advance this vital research, we emphasized the following accomplishments:
● Authored nine peer-reviewed scientific articles, including five as first or co-first author, published in high-impact journals such as Nature Microbiology, PLOS Pathogens, and Trends in Microbiology ● Contributed to one preprint and four research abstracts, showcasing active scholarly output ● Received 362 citations, highlighting the broad recognition of his work ● Six publications ranked among the top 10–20% most-cited microbiology articles for their respective years ● Received research funding support from the National Health and Medical Research Council (NHMRC) of Australia, an organization that funds work with major implications for public health
His contributions have advanced knowledge in bacterial outer membrane vesicles (OMVs), host-pathogen interactions, and inflammation signaling—all foundational to new vaccine platforms. His work has not only influenced the academic community but also supports innovation in public health strategies and infectious disease prevention.Our filing included a comprehensive presentation of his academic history, research accomplishments, and national relevance of the proposed endeavor.
His I-140 NIW petition was ultimately approved by USCIS in 1 year and 4 months, and notably, no Request for Evidence was issued during adjudication. We are proud to have contributed to this successful outcome and look forward to his continued success.